| 1. White, K. Encounters at Esalen, S. Cal. Psychiatric Assn. Newsletter, 1975 2. White, K. Tricyclic overdosage in a patient given combined tricyclic-MAOI treatment, American Journal of Psychiatry, 135:1411-1412, 1978 3. White, K., Bohart, R., Whipple, K., and Boyd, J. Lithium effects on normal subjects: relationship to plasma and RBC lithium levels, International Pharmacopsychiatry, 14:176-183, 1979 4. White, K., Cohen, J., Boyd, J., Nelson, R. Relationship between plasma, RBC, and CSF lithium concentrations in human subjects, International Pharmacopsychiatry, 14:663-669, 1979 5. White, K., Bohart, R., and Eaton, E. RBC lithium uptake ratios in manics, schizophrenics, and normals, Biological Psychiatry, 14:663-669, 1979 6. Eaton, E.M., Busk, J., Maloney, M.P., Sloane, R.B., Whipple, K., and White, K. Hemispheric dysfunction in schizophrenia: Assessment by visual perception tasks, Psychiatry Research, 1:325-332, 1979 7. White, K. and Sloane, R.B. Drugs in Brief Psychotherapy, Psychiatric Clinics of North America, 2:171-187, 1979 8. White, K. Advisability of combined treatment (letter), American Journal of Psychiatry, 135:729, 1979 9. Walker, N., White, K.L., Tornatore, F., Boyd, J.L., and Cohen, J.L. Lithium-methyldopa interactions in normal subjects. Drug Intell Clin Pharm, 1980; 14:638-639 10. White, K., Pistole, T., Boyd, J.L. Combined monoamine oxidase inhibitor-tricyclic antidepressant treatment: a pilot study, American Journal of Psychiatry, 137:1422-1425, 1980 11. White, K.L., Shih, J.L., Font, T.L., Young, H., Gelfand, R., and Boyd, J. Elevated platelet monoamine oxidase activity in nonendogenous depression. Proceedings of the Eleventh International Congress of the International Society of Psychoneuroendocrinology, Florence, Italy, 1980 12. White, K., Shih, J., Fong, T.L., Young, H., Gelfand, R., Boyd, J., Simpson, G., and Sloane, R.B. Elevated platelet monoamine oxidase activity in patients with nonendogenous depression, American Journal of Psychiatry, 137:1258-1259, 1980 13. White, K., Cohen, L.J., and Deandrea, D. An unusual movement disorder associated with neuroleptic treatment: tardive dyskinesia? The Journal of Nervous and Mental Disorders, 168:442-444 14. White, K.L. Tranylcypromine. Psychopharmacology Bulletin, 1981, 17:157-159 15. White, K. and Simpson, G. Combined MAOI-tricyclic antidepressant treatment: a reevaluation, Journal of Clinical Psychopharmacology, 1:264-279, 1981 16. White, K.L., Razani, J., Sloane, R.B., Simpson, G., and Cadow, G. MAOI vs. tricyclic: some clinical differences. Proceedings of the 134th Annual Meeting of the American Psychiatric Association, New Orleans, 1981 17. Shih, J.C., White, K.L., Razani, J., Simpson, G., and Sloane, R.B. Platelet monoamine oxidase activity in depressed patients. In: Usdin E and Weiner N (eds), Conference on the Function and Regulation of Monoamine Enzymes. Hampshire: McMillan Ltd, 1981 18. White, K., Busk, J., Eaton, E., Gomez, G., Razani, J., and Sloane, R.B. Dysphoric response to neuroleptics as a predictor of treatment outcome with schizophrenics, International Pharmacopsychiatry, 16:34-38, 1981 19. White, K.L., Simpson, G., Sloane, R.B., Razani, J., Cadow, B. and Palmer, R. Tranylcypromine treatment of depression. In: Perris C, Struwe G, and Janssen B (eds), Proceedings of the Third World Congress of Biological Psychiatry. Amsterdam: Elsevier, 1981, pp 406-409 20. Simpson, G.M., White, K.L., Boyd, J.L., Cooper, T.B., Halaris, A., Wilson, I.C., Raman, E.J., and Ruther, E. Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine, American Journal of Psychiatry, 139:358-360, 1982 21. White, K.L., O�Leary, J., Razani, J., Rebal, R., Sloane, R.B., Simpson, G., Palmer, R., and Cadow, B. New studies with a long-neglected antidepressant: tranylcypromine. Proceedings of the 13th Collegium Internationale Neuropsychopharmacologicum, Jerusalem, 1982 22. White, K.L., Razani, J., Simpson, G., Rebal, R. Sloane, R.B., O�Leary, J., and Palmer, R. Combined MAOI-tricyclic antidepressant treatment: a controlled trial. Psychopharmacology Bulletin, 1982, 18:180-181 23. Deandrea D., Walker, N., Mehlmauer, M. and White, K.L. Dermatological reactions to lithium: a critical review of the literature. J Clin Psychopharm, 1982; 2:199-294 24. Simpson, G. and White, K. Monoamine oxidase inhibitors: their use in clinical practice. Hospital and Community Psychiatry, 33:615-616, 1982 25. White, K., O'Leary, J., Razani, J., Rebal, R., and Palmer, R. Electrocardiographic effects of tranylcypromine vs. amitriptyline. Journal of Clinical Psychiatry, 44:91-92, 1983 26. White, K.L. Combined tricyclic and monoamine oxidase inhibitor antidepressants. Western Journal of Medicine, 1983; 138:406-407 27. Simpson, G., White, K., Pi, E., Razani, J., and Sloane, R.B. Monoamine oxidase inhibition and tyramine sensitivity in L-deprenyl treated subjects. Psychopharmacology Bulletin, 119:340-342, 1983 28. Slonim, D. and White, K. Homeopathy and psychiatry. The Journal of Mind and Behavior, 4:401-410, 1983 29. Slonim, D. and White, K.L. Mainstream psychiatry and homeopathy. J Am Inst Homeopath, 1982; 75:11-19 30. Simpson, G., White, K.L., Pi, E., Razani, J., and Sloane, R.B. MAO inhibition and tyramine sensitivity in deprenyl-treated subjects. Psychopharmacology Bulletin, 1983; 19: 340-343 31. Razani, R., White, K.L., White, J., Simpson, G., Sloane, R.B., Rebal, R., and Palmer, R. Amitriptyline and tranylcypromine antidepressant treatment: a controlled trial. Archives of General Psychiatry, 40:657-661, 1983 32. White, K.L., Macdonald, N., Razani, J., Shih, J., Boyd, J., Simpson, G. and Sloane, R.B. Platelet MAO activity in depression. Comprehensive Psychiatry, 1983; 44:91-93 33. Simpson, G., Pi, E. and White, K.L. Plasma drug levels and clinical response to antidepressants. J Clin Psychiatry, 1983; 44:27-34 34. Simpson, G., White, K.L., Pi, E.H., Razani, J. and Sloane, R.B. Tyramine sensitivity in deprenyl-treated patients. Syllabus and Scientific Proceedings of the 136th Annual Meeting of the American Psychiatric Association, New York, 1983 35. White, K. and Simpson, G. The combined use of MAOIs and tricyclics. Journal of Clinical Psychiatry, 45:67-69, 1984 36. Simpson, G. and White, K.L. Tyramine studies and the safety of MAOI drugs. Journal of Clinical Psychiatry, 1984; 45:59-61 37. Zimmerli, M. and White, K. The use of the dexamethasone suppression test to diagnose Briquet's syndrome (somatization disorder): report of a case. Journal of the American Osteopathic Association, 83:502-504, 1984 38. Baron, D.A., Shea, S., and White, K. The dexamethasone suppression test: some limitations in the general hospital setting. Journal of the American Osteopathic Association, 83:503-508, 1984 39. White, J., White, K., and Razani, J. Effects of endogenicity and severity on consistency of standard depression rating scales. Journal of Clinical Psychiatry, 45:260-261, 1984 40. White, K., Razani, J., Cadow, B., Gelfand, R., Palmer, R., Simpson, G., and Sloane, R.B. Tranylcypromine vs. nortriptyline vs. placebo in depressed outpatients: a controlled trial. Psychopharmacology, 82:258-262, 1984 41. White, K. and Simpson, G. The combined use of MAOIs and tricyclics. Journal of Clinical Psychiatry, 45:67-69, 1984 42. White, K. and Simpson, G. Should the use of MAO inhibitors be abandoned? Integrative Psychiatry, 3:34-45, 1985 43. Simpson, G.M., Frederickson, E., Palmer, R., Pi, E., Sloane, R.B., and White, K. Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use. Biological Psychiatry, 20:684-687, 1985 44. White, K., Keck, P.E., and Lipinski, J. Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report. Comprehensive Psychiatry, 27:211-214, 1986 45. Keck, P.E., Lipinski, J.F., and White, K. An inverse relationship between mania and obsessive-compulsive disorder: a case report (letter). Journal of Clinical Psychopharmacology, 6:123-124, 1986 46. Dilsaver, S.C. and White, K. Affective disorders and associated psychopathology: a family history study. Journal of Clinical Psychiatry, 47:162-169, 1986 47. White, K. and White, J. Tranylcypromine: patterns and predictors of response. Journal of Clinical Psychiatry, 47:380-382, 1986 48. Simpson, G.M., White, K.L. and Silver, P. Management of hypertensive crises in patients on MAOIs. In: Shader RI (ed), Current Concepts in MAOI Therapy, New York: Audio-Visual Medical Marketing, 1988. pp 45-52 49. White, K.L. and Simpson, G. Management of MAOI overdoses and hyperthermic crises. In Shader RI (ed), Current Concepts in MAOI Therapy, New York: Audiovisual Medical Marketing, 1988, pp 53-62 50. White, K. and Simpson, G. Treatment-resistant depression. Psychiatric Annals, 17:274-278, 1987 51. Cole, J.O., White, K.L. and Dugan, S. The drug therapy of obsessive compulsive disorders. McLean Hospital Journal, 1987; 12:39-66 52. Keck, P.E., Vuckovic, A., Pope, H.G., Nierenberg, A.A., Gribble, G.W. and White, K. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment. Journal of Clinical Psychopharmacology Research, 9:203-206, 1989 53. Keck, P.E., Pope, H.G., Nierenberg, A.A., Vuckovic, A., Gribble, G.W. and White, K.L. Monoamine oxidase inhibitor induction of hypertension without crisis. Journal of Clinical Psychopharmacology, 1989; 9:203-206 54. White, K.L., Quay, S.E., Steketee, G. Religion and guilt in OCD patients. Proceedings of the 142nd Annual Meeting of the American Psychiatric Association: New Research Program and Abstracts, NR 347, p. 188, 1989 55. Bodkin, J.A. and White, K. Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient. Journal of Clinical Psychiatry, 50:265-266, 1989 56. Chouinard, G., Goodman, W., Greist, J., Jenike, M., Rasmussen, S., White, K., Hackett, E., Gaffney, M., and Bick, P.A. Results of a double-blind placebo controlled study of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacology Bulletin, 26:279-284, 1990 57. White, K., Wykoff, W., Tynes, L.L., Schneider, L., and Zemansky, M. Fluvoxamine in the treatment of tricyclic-resistant depression. Psychiatric Journal of the University of Ottawa, 15:156-158, 1990 58. Tynes, L.L., White, K., and Steketee, G.B. Toward a new nosology of obsessive compulsive disorder. Comprehensive Psychiatry, 31:465-480, 1990 59. Yonkers, K.A., White, K.L. and McElroy S.L. Diagnosing late luteal phase Dysphoric disorder with comorbid mood disorders. Proceedings of the 143rd Annual Meeting of the American Psychiatric Association: New Research Program and Abstracts, NR 39, p. 61, New York, 1990 60. Bick, P.A., Hackett, E., Gaffney, M., Chouinard, G., Goodman, W., Greist, J., Jenike, M., Rasmussen, S., and White, K.L. Results of a double-blind placebo-controlled trial using a new serotonin uptake inhibitor, sertraline, in obsessive-compulsive disorder. Psychopharmacology Bulletin, 1990 61. White, K. and Cole, J. Pharmacotherapy of OCD in: Bellack, S. and Hersen, M. (Eds.), Handbook of Comparative Treatments for Adult Disorders, New York: Wiley, 1990 62. White, K.L., Schneider, L.S., Wykoff, W., Tynes, L.C., and Zemansky, M. Fluvoxamine efficacy in depression resistant to tricyclic antidepressants. Proceedings of the 17th Congress of the Collegium Internationale Neuropsychopharmacologicum, 1990, 1:76 63. Nierenberg, A.A. and White, K. What next? A review of pharmacologic strategies for treatment resistant depression. Psychopharmacology Bulletin, 26:429-460, 1991 64. Steketee, G. and White, K. When Once Is Not Enough: Help for Obsessive-Compulsives. Oakland: New Harbinger Publications, 1990 65. Steketee, G., Quay, S., and White, K. Religion and guilt in OCD patients. Journal of Anxiety Disorders, 5:359-367, 1991 66. McElroy, S.L., Pope, H.G., Hudson, J.I., Keck. P.E. and White, K.L. Kleptomania: a report of 20 cases. Am Journal of Psychiatry, 1991; 148:652-657 67. Rogers, M., White, K., Warshaw, M., Yonkers, K., Rodriguez-Villa, F., and Keller, M. The relationship between anxiety disorders and medical illness. Psychosomatic Medicine, 1991; 53:219-220 68. White, K. and Shields, J. Conversion of inpatient mental health benefits to outpatient benefits. Hospital and Community Psychiatry, 42:570-57, 1991 69. White, K., Yonkers, K., Goldenberg, I., Reich, J. and Keller, M. The infrequency of �pure culture� diagnoses among anxiety disorders. Clinical Neuropharmacology, 1992, 15(S1):56B 70. Yonkers, K. and White, K. Premenstrual exacerbation of depression: one process or two? Journal of Clinical Psychiatry, 53:289-292, 1992 71. Yonkers, K.A., Ellison, J.M., Shera, D.M., Pratt, L.A., Langford, L.M., Cole, J.O., White, K., Lavori, P.W., and Keller, M.B. Pharmacotherapy observed in a large prospective longitudinal study on anxiety disorders. Psychopharmacology Bulletin, 28:131-137, 1992 72. White, K., Kando, J., Park, T., Waternaux, C., and Brown, W.A. Side effects and the "blindability" of clinical drug trials. American Journal of Psychiatry, 149:1730-1731, 1992 73. White, K. Anxiety disorders: an overview. Rhode Island Medicine, 75:241-244, 1992 74. Mallya, G.K., White, K., Waternaux, C., and Quay, S. Short- and long-term treatment of obsessive-compulsive disorder with fluvoxamine. Annals of Clinical Psychiatry, 4:77-80, 1992 75. White, J., Davison, G.C., Haaga, D.A. and White, K. Cognitive bias in the articulated thoughts of depressed and nondepressed psychiatric patients. Journal of Nervous and Mental Disease, 180:77-81, 1992 76. White, K., Kando, J., Park, T., Waternaux, C., and Brown, W. Side effects and the �blindability� of clinical drug trials. American Journal of Psychiatry, 1992: 149:1730-1731 77. Mallya, G., White, K. and Gunderson, J. Is there a serotonergic withdrawal syndrome? (letter). Biological Psychiatry, 33:851-852, 1993 78. Reich, J., Warshaw, M., Peterson, L.G., White, K., Keller, M., Lavori, P., and Yonkers, K.A. Comorbidity of panic and major depressive disorder. Journal of Psychiatric Research, 27S:23-33, 1993 79. Keller, M.B., Yonkers, K.A., Warshaw, M.G., Gollan, J.K., Masston, A.O., White, K., Swartz A.R., Pratt, L,A., Reich, J. and Lavori, P.W. Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up. Journal of Nervous and Mental Disease 80. Vincent, M. and White, K. Patient violence toward a nurse: predictable and preventable? Journal of Psychosocial Nursing, 32:30-32, 1994 81. Rogers, M.P., White, K., Warshaw, M.G., Yonkers, K.A., Rodriguez-Villa, F., Chane, G., and Keller, M.B. Prevalence of medical illness in patients with anxiety disorders. International Journal of Psychiatry in Medicine, 24:83-96, 1994 82. Oxenkrug, G.F., Requintina, P.J., McIntyre, I.M., and White, K. Chronopharmacologic study of moclobemide effects on the rat pineal melatonin biosynthesis. Journal of Neural Transmission, 41S:335-337, 1994 83. Oxenkrug, G.F., Requintina, P.J., McIntyre, I.M., and White, K. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis. Journal of Neural Transmission, 41S:381-384, 1994 84. Greist, J., Chouinard, E., DuBoff, E., Halaris, A., Kim, S.W., Koran, K., Liebowitz, M., Lydiard, R.B., Rasmussen, S., White, K., et al. Double-blind parallel comparisons of three doses of sertraline and placebo in outpatients with obsessive-compulsive disorder, Archives of General Psychiatry, 52:289-295, 1995 85. Goldenberg, I.M., White, K., Yonkers, K., Reich, J., Warshaw, M.G., Goisman, R.M., and Keller, M.B. The infrequency of "pure culture" diagnosis among the anxiety disorders. Journal of Clinical Psychiatry, 57:528-533, 1996 86. Goodman, W.K., Kozak, M.J., Liebowitz, M., and White, K. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. International Clinical Psychopharmacology, 11:21-29, 1996 87. White, K.L. Ignoring snoring: A dangerous truce. Published on-line at Suite101.com, August 7, 2000. See: http://www.suite101.com/article.cfm/7505/41407 88. White, K.L. Did sleep apnea afflict Johannes Brahms? Published on-line at Suite101.com, August 15, 2000. See: http://www.suite101.com/article.cfm/7505/46062 89. White, K.L. Dickens� �Fat Boy:� A classic case of what? Published on-line at Suite101.com, August 25, 2000. See: http://www.suite101.com/article.cfm/7505/46600 90. White, K.L. Phantom death. Published on-line at Suite101.com, September 1, 2000. See: http://www.suite101.com/article.cfm/7505/47912 91. White, K.L. Drowsy drivers beware! Published on-line at Suite101.com, September 19, 2000. See http://www.suite101.com/article.cfm/7505/48205 92. White, K.L. Postoperative catastrophes with OSA patients: 2 sad accounts. Published on-line at Suite101.com, September 22, 2000. See http://www.suite101.com/article.cfm/7505/48479 93. White, K.L. To nap or not to nap: Is that the question? Published on-line at Suite101.com, September 29, 2000. See http://www.suite101.com/article.cfm/7505/49201 94. White, K.L. �License to kill.� Published on-line at Suite101.com, October 6, 2000. See http://www.suite101.com/article.cfm/7505/49663 95. White, K.L. �Sleepiness:� What does it mean? Published on-line at Suite101.com, October 10, 2000. See http://www.suite101.com/article.cfm/7505/49957 96. White, K.L. How to educate yourself on apnea? Published on-line at Suite101.com, October 31, 2000. See http://www.suite101.com/article.cfm/7505/51757 97. White, K.L. How to find diagnosis and treatment for apnea? Published on-line at Suite101.com, November 10, 2000. See http://www.suite101.com/article.cfm/7505/52318 98. White, K.L. Why sleep? Published on-line at Suite101.com, November 14, 2000. See http://www.suite101.com/article.cfm/7505/5644 99. White, K.L. Grief or depression? How to tell when grieving goes too far. Published on-line at FitnessHeaven.com, October 13, 2000. See http://www.fitnessheaven.com/wellness/grief/69,26993.asp 100. White, K.L. Exercise helps apnea: blessing or curse? Published on-line at Suite101.com, December 5, 2000. See http://www.suite101.com/article.cfm/7505/54336 101. White, K.L. An operation obsession. Published on-line at Suite101.com, December 8, 2000. See http://www.suite101.com/article.cfm/7505/54633 102. White, K.L. Only the Internet . . . Published on-line at Suite101.com, December 12, 2000. See http://www.suite101.com/article.cfm/7505/54336 103. White, K.L. Pictures of Sleep. Published on-line at Suite101.com, December 19, 2000. See http://www.suite101.com/article.cfm/7505/54925 104. White, K.L How to Manage Your Doctor! Published on-line at Suite101.com, December 22, 2000 at http://www.suite101.com/article.cfm/7505/55439 105. White, K.L. Antipsychotic Drug Use Increases Risk of Thromboembolism, Pharmacy Practice News, in press 106. White, K.L. Putting Drug-Herb Interactions in Perspective. Published on-line at FitnessHeaven.com on September 19, 2000 at http://www.fitnessheaven.com/health/medication/16,26576.asp 107. White, K.L. A Minor Matter of Delay . . .Published on-line at Suite101.com on January 2, 2001, at http://www.suite101.com/article.cfm/7505/56189 108. White, K.L. Hoseheads, Unite! Published on-line at Suite101.com on December 29, 2000, at http://www.suite101.com/article.cfm/7505/55856 109. White, K.L. dreamdeath, Published on-line at Suite101.com on January 5, 2001, at http://www.suite101.com/article.cfm/7505/56384 110. White, K.L. How To Understand Your Sleep Study Results, published at Suite101.com on January 12, 2001, at http://www.suite101.com/article.cfm/7505/57133 |